Literature DB >> 17554336

In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Marius Wernig1, Alexander Meissner, Ruth Foreman, Tobias Brambrink, Manching Ku, Konrad Hochedlinger, Bradley E Bernstein, Rudolf Jaenisch.   

Abstract

Nuclear transplantation can reprogramme a somatic genome back into an embryonic epigenetic state, and the reprogrammed nucleus can create a cloned animal or produce pluripotent embryonic stem cells. One potential use of the nuclear cloning approach is the derivation of 'customized' embryonic stem (ES) cells for patient-specific cell treatment, but technical and ethical considerations impede the therapeutic application of this technology. Reprogramming of fibroblasts to a pluripotent state can be induced in vitro through ectopic expression of the four transcription factors Oct4 (also called Oct3/4 or Pou5f1), Sox2, c-Myc and Klf4. Here we show that DNA methylation, gene expression and chromatin state of such induced reprogrammed stem cells are similar to those of ES cells. Notably, the cells-derived from mouse fibroblasts-can form viable chimaeras, can contribute to the germ line and can generate live late-term embryos when injected into tetraploid blastocysts. Our results show that the biological potency and epigenetic state of in-vitro-reprogrammed induced pluripotent stem cells are indistinguishable from those of ES cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17554336     DOI: 10.1038/nature05944

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  989 in total

Review 1.  Pluripotency of human embryonic and induced pluripotent stem cells for cardiac and vascular regeneration.

Authors:  Kenneth R Boheler
Journal:  Thromb Haemost       Date:  2010-05-10       Impact factor: 5.249

Review 2.  The genetic and phenotypic basis of infertility in men with pediatric urologic disorders.

Authors:  Michael H Hsieh; Adam Hollander; Dolores J Lamb; Paul J Turek
Journal:  Urology       Date:  2010-05-07       Impact factor: 2.649

Review 3.  Induced pluripotent stem cells in dermatology: potentials, advances, and limitations.

Authors:  Ganna Bilousova; Dennis R Roop
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

Review 4.  Nuclear reprogramming to a pluripotent state by three approaches.

Authors:  Shinya Yamanaka; Helen M Blau
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

Review 5.  Vascular smooth muscle cells in cerebral aneurysm pathogenesis.

Authors:  Robert M Starke; Nohra Chalouhi; Dale Ding; Daniel M S Raper; M Sean Mckisic; Gary K Owens; David M Hasan; Ricky Medel; Aaron S Dumont
Journal:  Transl Stroke Res       Date:  2013-10-10       Impact factor: 6.829

Review 6.  Learning the molecular mechanisms of the reprogramming factors: let's start from microRNAs.

Authors:  Chao-Shun Yang; Tariq M Rana
Journal:  Mol Biosyst       Date:  2012-10-05

7.  An expressed retrogene of the master embryonic stem cell gene POU5F1 is associated with prostate cancer susceptibility.

Authors:  Joan P Breyer; Daniel C Dorset; Travis A Clark; Kevin M Bradley; Tiina A Wahlfors; Kate M McReynolds; William H Maynard; Sam S Chang; Michael S Cookson; Joseph A Smith; Johanna Schleutker; William D Dupont; Jeffrey R Smith
Journal:  Am J Hum Genet       Date:  2014-02-27       Impact factor: 11.025

8.  Generation of iPS cells using defined factors linked via the self-cleaving 2A sequences in a single open reading frame.

Authors:  Lijian Shao; Wei Feng; Yan Sun; Hao Bai; Jun Liu; Caroline Currie; Jaejung Kim; Rafael Gama; Zack Wang; Zhijian Qian; Lucy Liaw; Wen-Shu Wu
Journal:  Cell Res       Date:  2009-03       Impact factor: 25.617

9.  Multiple genes exhibit phenobarbital-induced constitutive active/androstane receptor-mediated DNA methylation changes during liver tumorigenesis and in liver tumors.

Authors:  Jennifer M Phillips; Jay I Goodman
Journal:  Toxicol Sci       Date:  2009-02-20       Impact factor: 4.849

10.  Critical regulation of miR-200/ZEB2 pathway in Oct4/Sox2-induced mesenchymal-to-epithelial transition and induced pluripotent stem cell generation.

Authors:  Guiying Wang; Xudong Guo; Wujun Hong; Qidong Liu; Tingyi Wei; Chenqi Lu; Longfei Gao; Dan Ye; Yi Zhou; Jie Chen; Jianmin Wang; Minjuan Wu; Houqi Liu; Jiuhong Kang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.